Study to Evaluate the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (TSR-042) in Participants With Platinum Resistant Ovarian Cancer
Clinical trial NCT03955471 · TERMINATED
Trial details
- NCT number
- NCT03955471
- Sponsor
- Tesaro, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-03
- Primary completion
- 2021-08-18
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.